PALX · Palomino Laboratories Inc. · Executive Compensation
Market Cap
$386.91M
Shares
27.64M
Volume · Oct 15
4556
Avg daily vol (3M)
3955
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard Ogawa | Secretary | Appointed | 2025-10-06 |
| Jason Tu | Chief Accounting Officer | Appointed | 2025-10-06 |
| Steve DenBaars | directors of the Parent | Appointed | 2025-10-06 |
| Richard Ogawa | directors of the Parent | Appointed | 2025-10-06 |
| Jeff Shealy | President and Chief Executive Officer | Appointed | 2025-10-06 |
| Jeff Shealy | directors of the Parent | Appointed | 2025-10-06 |
| Jason Tu | Chief Accounting Officer | Appointed | 2025-10-06 |
| Richard Ogawa | Secretary | Appointed | 2025-10-06 |
| Steven DenBaars | board of directors | Appointed | 2025-10-06 |
| Mr. Pereira | all officer positions | Resigned | 2025-10-06 |
| Jeff Shealy | President and Chief Executive Officer | Appointed | 2025-10-06 |
| Richard Ogawa | board of directors | Appointed | 2025-10-06 |
| Jeff Shealy | board of directors | Appointed | 2025-10-06 |
| Mr. Pereira | board of directors | Resigned | 2025-10-06 |
Leadership
- Jeff Shealy CEO, Board Member
- Richard Ogawa General Counsel, Board Member
- Jason Tu Chief Accounting Officer
- Steve DenBaars Board Member
- Steven DenBaars Board Member